Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?

Reports of Practical Oncology and Radiotherapy

Volumn 20, Issue 1, 2015, Pages 1-11

  Ciria, Juan Pablo ^a   Eguiguren, Mikel ^a   Cafiero, Sergio ^a   Uranga, Intza ^a   Diaz de Cerio, Ivan ^a   Querejeta, Arrate ^a   Urraca, Jose Maria ^a   Minguez, Julian ^a   Guimon, Elena ^a   Puertolas, Jose Ramón ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

Locally advanced rectal cancer; Neoadjuvant radiation therapy; Prognostic factors; Short course preoperative radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; HUMAN; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PREOPERATIVE PERIOD; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CARCINOMA; RECURRENCE RISK; REVIEW; SHORT COURSE THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 84916236106     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2014.06.003     Document Type: Review

References (73)

1. Minsky B.D., Rödel C., Valentini V. Short-course radiation versus long-course chemoradiation for rectal cancer. J Natl Compr Canc Netw 2012, 10(October (10)):1223-1231.
2. Rödel C., Trojan J., Bechstein W.O., Woeste G. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?. Dig Dis 2012, 30(Suppl. 2):102-108. 10.1159/000342038.
3. Phang P.T., Wang X. Current controversies in neoadjuvant chemoradiation of rectal cancer. Surg Oncol Clin N Am 2014, 23(January (1)):79-92. 10.1016/j.soc.2013.09.008.
4. Glimelius B., Pahlman L., Cervantes A., ESMO Guidelines Working Group Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(Suppl. 6):vi81-vi88.
5. Valentini V., Glimelius B., Haustermans K., Marijnen C.A., Rödel C., Gambacorta M.A., et al. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review. Radiother Oncol 2014, 110(1):195-198.
6. Di Genesio Pagliuca M., Turri L., Munoz F., Melano A., Bacigalupo A., Franzone P., et al. Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)". Tumori 2013, 99(January-February (1)):61-67. 10.1700/1248.13790.
7. Engelen S.M., Maas M., Lahaye M.J., Leijtens J.W., van Berlo C.L., Jansen R.L., et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 2013, 49(10):2311-2320.
8. Sautter-Bihl M.L., Hohenberger W., Fietkau R., Roedel C., Schmidberger H., Sauer R. MRI-based treatment of rectal cancer: is prognostication of the recurrence risk solid enough to render radiation redundant?. Ann Surg Oncol 2014, 21(January (1)):197-204. 10.1245/s10434-013-3236-7.
9. Stearns M.W., Deddish M.R., Quan S.H., Leaming R.H. Preoperative roentgen therapy for cancer of the rectum and rectosigmoid. Surg Gynecol Obstet 1974, 138:584-586.
10. Higgins G.A., Conn J.H., Jordan P.H., Humphrey E.W., Roswit B., Keehn R.J. Preoperative radiation therapy for rectal cancer. Ann Surg 1975, 181:624-631.
11. Higgins G.A., Humphrey E.W., Dwight R.W., Roswit B., Lee L.E., Keehn R.J. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer 1986, 58:352-359.
12. Second report of the MRC Working Party. The evaluation of low dose preoperative X-ray therapy in rectal carcinoma: results of a randomly controlled trial. Br J Surg 1984, 71:21-25.
13. Gérard A., Berrod J.L., Pene F., Laughier A., Bruckner R., Camelot G., et al. Interim analysis of phase III study on preoperative radiation therapy in resectable rectal carcinoma. Trial of the Gastrointestinal Tract Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC). Cancer 1985, 55(10):2373-2379.
14. Gérard A., Buyse M., Nordlinger B., Loygue J., Pène F., Kempf P., et al. Preoperative radiation therapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988, 208:606-614.
15. Stockholm Rectal Cancer Study Group Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomised trial. Cancer 1990, 66:49-55.
16. Pahlman L., Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicentric trial. Ann Surg 1990, 211:187-195.
17. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal cancer. Swedish Rectal Cancer Trial. Br J Surg 1993, 80:1333-1337.
18. Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal cancer. Swedish Rectal Cancer Trial. Eur J Surg 1996, 162:397-402.
19. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997, 336(14):980-987. [Erratum in N Engl J Med 1997;336(21):1539].
20. Lavery I.C., Fazio V.W., Lopez-Kostner F. Radiotherapy for rectal cancer. Comment on improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997, 337(5):346-347. [author reply 347-8].
21. Marijnen C.A.M., Nagtegaal I.D., Klein Kranenbarg E., Hermans J., Van de Velde C.J.H., Leer J.W.H., et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001, 19:1976-1984.
22. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
23. Peeters K.C., Marijnen C.A., Nagtegaal I.D., Kranenbarg E.K., Putter H., Wiggers T., et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007, 246(5):693-701.
24. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986, 1:1479-1482.
25. MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460.
26. Heald R.J., Moran B.J., Ryall R.D.H., Sexton R., MacFarlane J.K. The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998, 133:894-899.
27. Houbiers J.G., Brand A., van de Watering L.M., Hermans J., Verwey P.J., Bijnen A.B., et al. Randomized controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994, 334:573-578.
28. Kapiteijn E., Putter H., van de Velde C.J., Cooperative investigators of the Dutch ColoRectal Cancer Group Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002, 89(9):1142-1149.
29. Martling A.L., Holm T., Rutqvist L.E., Moran B.J., Heald R.J., Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000, 356:93-96.
30. Van Gijn W., Marijnen C.A., Nagtegaal I.D., Kranenbarg E.M., Putter H., Wiggers T., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12 year follow-up of the multicenter, randomized controlled TME trial. Lancet Oncol 2011, 12(6):575-582. 10.1016/S1470-2045(11)70097-3.
31. Marijnen C.A., Kapiteijn E., van de Velde C.J., Martijn H., Steup W.H., Wiggers T., et al. Acute side effects and complications after short-term preoperative radiotherapy combined with mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002, 20:817-825.
32. Dahlberg M., Glimelius B., Graf W., Påhlman L. Preoperative irradiation affects functional results after surgery for rectal cancer. Results from a randomized study. Dis Colon Rectum 1998, 41:543-551.
33. Peeters K.C., Kapiteijn E., van de Velde C.J., Dutch ColoRectal Cancer Group Managing rectal cancer: the Dutch experience. Colorectal Dis 2003, 5:423-425.
34. Guimelius B. Adjuvant chemotherapy in rectal cancer: an issue or a nonissue? [Comment on Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials (Ann Oncol 2010)]. Ann Oncol 2010, 21(9):1739-1741.
35. Breugom A.J., van den Broek C.B.M., van Gijn W., et al. The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemoradiation followed by TME-surgery: The PROCTOR/SCRIPT study. 2013 European Cancer Congress. Abstract 1 2013.
36. Sebag-Montefiore D., Stephens R.J., Steele R., Monson J., Grieve R., Khanna S., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820.
37. Sebag-Montefiore D., Steele R., Monson J., Couture J., de Metz C., Pugh C., et al. The MRC C016 [MRC CR07/NCIC-CTG C016] trial after a median follow-up of 8 years (abstract OC-0219). Radiother Oncol 2012, 103(Suppl. 1):S85.
38. Adam I.J., Mohamdee M.O., Martin I.G., Scott N., Finan P.J., Johnston D., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994, 344:707-711.
39. De Caluwé L., Van Nieuwenhove Y., Ceelen W.P. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2013, 2(February):CD006041. 10.1002/14651858.CD006041.pub3.
40. Stephens R.J., Thompson L.C., Quirke P., Steele R., Grieve R., Couture J., et al. Impact of short course preoperative radiotherapy for rectal cancer patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol 2010, 28:4233-4239.
41. Guckenberger M., Saur G., Wehner D., Thalheimer A., Kim M., Germer C.T., et al. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Radiother Oncol 2013, 108(August (2)):326-330. 10.1016/j.radonc.2013.08.022.
42. Ciammella P., Ruggieri M.P., Galeandro M., D'Abbiero N., Giunta A., Iotti C. Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life. Radiol Med 2013, 118(December (8)):1397-1411.
43. Gerard J.P., Conroy T., Bonnetain F., Bouché O., Chapet O., Closon-Dejardin M.T., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
44. Bosset J.F., Collette L., Calais G., Mineur L., Maingon P., Radosevic-Jelic L., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
45. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., Michalski W., Bebenek M., Pudełko M., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24.
46. Pietrzak L., Bujko K., Nowacki M.P., Kepka L., Oledzki J., Rutkowski A., et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol 2007, 84:217-225.
47. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., Michalski W., Bebenek M., Kryj M. Long-term results of a randomised trial comparing short-course radiotherapy vs preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006, 93:1215-1223.
48. Ngan S.Y., Burmeister B., Fisher R.J., Solomon M., Goldstein D., Joseph D., et al. Randomized trial of short course radiotherapy versus long course chemoradiation comparing rates of local recurrence in patients with t3 rectal cancer. Trans-Tasman Radiation Oncology Group trial 01-04. J Clin Oncol 2012, 30(31):3827-3833. [Erratum in J Clin Oncol 2013;31(3):399]. 10.1200/JCO.2012.42.9597.
49. Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
50. Sauer R., Liersch T., Merkel S., Fietkau R., Hohenberger W., Hess C., et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012, 30(16):1926-1933.
51. Yeo S.G., Oh J.H., Kim D.Y., Baek J.Y., Kim S.Y., Park J.W., et al. Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01). Int J Radiat Oncol Biol Phys 2013, 86(May (1)):34-39. 10.1016/j.ijrobp.2012.11.018.
52. Siegel R., Burock S., Wernecke K.D., Kretzschmar A., Dietel M., Loy V., et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 2009, 9:50.
53. Garcia-Aguilar J., Smith D.D., Avila K., Bergsland E.K., Chu P., Krieg R.M., for the Timing of Rectal Cancer Response to Chemoradiation Consortium Optimal timing of surgery after chemoradiation for advanced rectal cáncer: preliminary results of a multicenter, non-randomized phase II prospective trial. Ann Surg 2011, 254(1):97-102.
54. Nilsson P.J., van Etten B., Hospers G.A.P., Pahlman L., van de Velde C.J.H., Beets-Tan R.G.H., et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer-the RAPIDO trial. BMC Cancer 2013, 13:279-287.
55. Schrag D. Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol 2013, 14:350-364.
56. Schrag D., Weiser M.R., Goodman K.A., Gonen M., Hollywood E., Cercek A., et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 2014, 32(6):513-518.
57. Beets G.L., Beets-Tan R.G.H., Lahaye M., Nagtegaal I.D., van del Velde C.J.H., Marijnen C.A.M. Mechanisms of local recurrence after rectal cancer resection. What can we learn from the Dutch TME Trial? (abstract no. 011.04). Oral session presented at the European Multidisciplinary Colorectal Cancer Congress, 12-14 Feb 2006, Berlin, Germany. Ann Oncol 2006, 17(Suppl. 1):ii4.
58. Kusters M., Marijnen C.A., van de Velde C.J., Rutten H.J., Lahaye M.J., Kim J.H., et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010, 36(5):470-476.
59. López-Kostner F., Fazio V.W., Vignali A., Rybicki L.A., Lavery I.C. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 2001, 44:173-178.
60. García-Aguilar J., Cromwell J.W., Marra C., Lee S.H., Madoff R.D., Rothenberger D.A. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001, 44:1743-1748.
61. Yamada K., Ishizawa T., Niwa K., Chuman Y., Akiba S., Aikon T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001, 88:988-993.
62. Asoglu O., Karanlik H., Muslumanoglu M., Igci A., Emek E., Ozmen V., et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007, 33(10):1199-1206.
63. Radiation oncology: rationale, technique, results 2003, 27. Mosby, St Louis, MO. 8th ed. J.D. Cox, K.K. Ang (Eds.).
64. Roels S., Duthoy W., Haustermans K., Penninckx F., Vandecaveye V., Boterberg T., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006, 65(4):1129-1142.
65. Nijkamp J., Kusters M., Beets-Tan R.G., Martijn H., Beets G.L., van de Velde C.J., et al. Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys 2011, 80(1):103-110.
66. Cerezo L., Ciria J.P., Arbea L., Cafiero S., Cellini F. Current treatment of rectal cancer adapted to the individual patient. Rep Pract Oncol Radiother 2013, 18(6):353-362.
67. Mercury Study Group Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer results of the MERCURY study. Radiology 2007, 243:132-139.
68. Mercury Study Group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006, 333:779.
69. Curvo-Semedo L., Lambregts D.M., Maas M., Beets G.L., Caseiro-Alves F., Beets-Tan R.G. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 2012, 35(June (6)):1365-1371. 10.1002/jmri.23589.
70. Van den Broek C.B., Vermeer T.A., Bastiaannet E., Rutten H.J., van de Velde C.J., Marijnen C.A. Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients. Eur J Cancer 2013, 49(15):3131-3139.
71. Pettersson D., Cedermark B., Holm T., Radu C., Påhlman L., Glimelius B., et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010, 97:580-587.
72. Hatfield P., Hingorani M., Radhakrishna G., Cooper R., Melcher A., Crellin A., et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 2009, 92(2):210-214.
73. Radu C., Berglund A., Påhlman L., Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer: a retrospective study. Radiother Oncol 2008, (87):343-349.